IN VITRO DIAGNOSTICS Mergers & Acquisitions Amgen Inc. deCode genetics EHF Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash. (Dec.) DeCODE was fo
Songwriter Tom Petty observed that “The waiting is the hardest part.” For those who have lived through the past few years in the medical device industry, Petty is truly preaching to the choir. The the
In Vitro Diagnostics ACS Biomarker BV ACS Biomarker closes its Series A round ACS Biomarker BV (cardiovascular biomarkers) has raised an undisclosed amount through its Series A venture round. Life